BLUE WATER BIOTECH INC (BWV) Forecast, Price Target & Analyst Ratings

NASDAQ:BWV • US09610B1089

Current stock price

0.1802 USD
-0.01 (-5.16%)
At close:
0.19 USD
+0.01 (+5.44%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BLUE WATER BIOTECH INC (BWV).

Forecast Snapshot

Consensus Price Target

Price Target
$9.18
+ 4,994.34% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q4 / 2023
EPS Estimate
-$0.21
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
45.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$9.18
Upside
+ 4,994.34%
From current price of $0.18 to mean target of $9.18, Based on 8 analyst forecasts
Low
$9.09
Median
$9.18
High
$9.45

Price Target Revisions

1 Month
0.00%
3 Months
38.46%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for BWV. The average price target is 9.18 USD. This implies a price increase of 4994.34% is expected in the next year compared to the current price of 0.1802.
The average price target has been revised upward by 38.46% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

BWV Current Analyst RatingBWV Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

BWV Historical Analyst RatingsBWV Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
45.00%
BWV was analyzed by 8 analysts. The buy percentage consensus is at 45. So analysts seem to be rather negative about BWV.
In the last month the buy percentage fell by 32 points. So the trust of analysts is decreasing.
BWV was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-09-13Maxim GroupDowngrade Buy -> Hold
2023-04-26HC Wainwright & Co.Maintains Buy
2023-02-01HC Wainwright & Co.Reiterate Buy
2022-12-09HC Wainwright & Co.Initiate Buy
2022-12-08Maxim GroupInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q4 / 2023
EPS Estimate
-$0.21
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-7.12%
Number of Analysts
2

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
-31.25%

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2025

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
BWV revenue by date.BWV revenue by date.
N/AN/AN/A
EBITDA
YoY % growth
BWV ebitda by date.BWV ebitda by date.
-880K-1.62M
-84.09%		-3.42M
-111.11%		-13.47M
-293.86%		N/AN/AN/A
EBIT
YoY % growth
BWV ebit by date.BWV ebit by date.
-880K-1.62M
-84.09%		-3.42M
-111.11%		-13.48M
-294.15%		N/A
0.96%		N/A
-20.00%		N/A
-27.59%
Operating Margin
BWV operating margin by date.BWV operating margin by date.
N/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
BWV eps by date.BWV eps by date.
N/AN/AN/AN/AN/A
36.13%		N/A
-11.84%		N/A
-16.47%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 23
EPS
Q2Q % growth		-0.21
-7.12%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		-3.829M
-17.81%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

BWV Yearly EPS VS EstimatesBWV Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 -0.2 -0.4 -0.6 -0.8 -1

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
5.31%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

BLUE WATER BIOTECH INC / BWV Forecast FAQ

What is the average price target for BLUE WATER BIOTECH INC (BWV) stock?

8 analysts have analysed BWV and the average price target is 9.18 USD. This implies a price increase of 4994.34% is expected in the next year compared to the current price of 0.1802.

Can you provide the consensus estimates for BLUE WATER BIOTECH INC next earnings?

The consensus EPS estimate for the next earnings of BLUE WATER BIOTECH INC (BWV) is -0.21 USD and the consensus revenue estimate is 0 USD.